Correlation Between Vaccinex and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Neoleukin Therapeutics, you can compare the effects of market volatilities on Vaccinex and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Neoleukin Therapeutics.
Diversification Opportunities for Vaccinex and Neoleukin Therapeutics
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Vaccinex and Neoleukin is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of Vaccinex i.e., Vaccinex and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between Vaccinex and Neoleukin Therapeutics
Given the investment horizon of 90 days Vaccinex is expected to under-perform the Neoleukin Therapeutics. In addition to that, Vaccinex is 1.4 times more volatile than Neoleukin Therapeutics. It trades about -0.07 of its total potential returns per unit of risk. Neoleukin Therapeutics is currently generating about 0.09 per unit of volatility. If you would invest 42.00 in Neoleukin Therapeutics on August 29, 2024 and sell it today you would earn a total of 27.00 from holding Neoleukin Therapeutics or generate 64.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 31.45% |
| Values | Daily Returns |
Vaccinex vs. Neoleukin Therapeutics
Performance |
| Timeline |
| Vaccinex |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Vaccinex and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vaccinex and Neoleukin Therapeutics
The main advantage of trading using opposite Vaccinex and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.| Vaccinex vs. Protara Therapeutics | Vaccinex vs. Monopar Therapeutics | Vaccinex vs. Surrozen | Vaccinex vs. Salarius Pharmaceuticals |
| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |